Jabra Hearing Aids: Prices, FDA Records, Recalls and Plan Caps

What Jabra Enhance charges for the Select M series

In October 2026, Jabra Enhance listed the Select M1 at $1,195 a pair, the Select M2 at $1,695 a pair and the Select M3 at $1,995 a pair. We read those prices on its product page, linked in the sources below.

Each figure covers the pair. We recorded the price only; charger and care services are on the seller's page, so confirm them there before you order. Prices move: treat these as a dated reading and check the current figure with the seller.

What FDA records say about each model

The table above has five rows, one for each set of Jabra names in FDA's records.

The M series shares one number. FDA's device listing names M1, M2, M3 and 550 under 510(k) K254108, with codes QUH and OSM, and does not split the codes by model. The decision is dated June 25, 2026. The summary filed with it names only the Jabra Enhance Select 550, so check an M1, M2 or M3 label for the direct-use indications below.

The summary describes direct use. It covers people 18 years of age or older with perceived mild to moderate hearing impairment and says "No pre-programming or hearing test is necessary". It describes direct-to-consumer sale and use without a hearing care professional. The prescription code OSM is there for an optional feature: remote adjustment by hearing care professionals.

The Select name covers more than one record. Select 50 through 700 sit on a listing with code QUG and no 510(k) number; the summary calls Select 300 "510(k)-exempt under product code QUG". A Select 700 and a Select M2 have different FDA records. Enhance Plus has its own number, K213424. The Pro and Max names sit on a shared GN listing with code OSM and no 510(k) number for its hearing aid code.

Select 500 has its own listing. An FDA registration listing search for the name Enhance Select 500 returns a listing under code QUG, owned by GN Hearing A/S. Jabra lists an Enhance Select 500 guide on its start page, and its user guide page files it as "Jabra Enhance Select 500 OTC". We attach no other GN device record to the 500 unless the record names it.

A listing shows that a name is registered with FDA; the seller can say whether a model is on sale today. A 510(k) decision finds substantial equivalence to a predicate; it does not rate performance for one person.

Jabra Enhance Select 300 and Select 700: what the user guides say

Jabra Enhance's product page, read on November 7, 2026, offers the Select M1, M2 and M3 and lists no Select 300 or Select 700, so we have no current price for either. Each model still has its own user guide on Jabra Enhance's site, and the figures below come from those guides.

Select 300

The guide describes rechargeable receiver-in-ear aids, type designation CARR104Q. It states a battery lifetime of 24 hours, and says operating time depends on active features, wireless accessories, hearing loss, battery age and sound environment. Its service-life table gives 5 years for the aid and for the built-in battery, 2 years for receivers and 3 months for a dome. It names three domes, tulip, closed and open, with the tulip in one size, and says to change domes every 3 months or more often.

Select 700

The Select 700 guide also describes rechargeable receiver-in-ear aids, under type designation DURR1B04. It gives a battery lifetime of 24 hours typical and 30 hours maximum. Its service-life table matches the Select 300's: 5 years for the aid and the battery, 2 years for receivers, 3 months for a dome. Closed and open domes come in small, medium and large, the tulip in one size, and the guide says to change domes every 3 months or sooner.

Where the two sit in FDA's records

Both guides give the same intended use: adults 18 years of age or older with perceived mild to moderate hearing impairment, in direct-to-consumer sale without a hearing care professional. FDA's 2023 listing names Select 300 and Select 700 under code QUG with no 510(k) number, and the K254108 summary cites Select 300 only as a reference device. The M series prices above belong to other models and don't apply to these two.

Jabra Enhance charging cases: what the maker and FDA list

Jabra Enhance's charging case page, read on November 7, 2026, makes two points about its cases, summed up here in our words.

In FDA's device identification database (GUDID), Gn Hearing A/S labels two C-5 chargers carrying the Jabra name.

Both records sit under product code QUH, both are in commercial distribution, and on both the over-the-counter field reads true. Neither record names the aid it serves, so match the case to the model name on your aids before you buy one.

FDA recall and adverse event searches for Jabra

We searched FDA's recall and adverse event databases through openFDA on October 30, 2026.

Recalls: no match for these names. The device recall database returned no match for the product names Jabra, Enhance Select, Enhance Pro, Enhance Plus, Enhance Max or Enhance Clear, or for the firm names Jabra, GN ReSound or GN Consumer. Its data was last updated on October 29, 2026.

One recall under the firm name GN Hearing. Event 83906 began on September 18, 2019 and was terminated on May 31, 2023. FDA classified the recall as Class II. The stated reason is a software bug in a service and repair tool that altered sound amplification settings in a limited number of repaired behind-the-ear and in-the-ear aids. The model numbers it lists carry no Jabra or Enhance name.

Adverse event reports: three, unverified. A search of the brand-name field of MAUDE, FDA's adverse event report database, for those six product names returned three distinct reports, received from 2021 to 2024: 3005650109-2021-00011, MW5108012 and MW5150512. Its data was last updated on October 13, 2026. These reports are unverified, and the number gives neither a rate nor a judgment of quality: MAUDE records no count of aids in use, and reports come from manufacturers as well as health care professionals, patients and consumers. The count also moves with the field searched. Searching the report narratives finds other reports filed under other brand names, and a search on the firm name GN Hearing covers its other brands, so we attribute neither to Jabra.

Who makes Jabra Enhance hearing aids

Jabra Enhance hearing aids come from GN Hearing A/S of Ballerup, Denmark, the owner-operator named on the M series listing. FDA records that site as developing specifications without manufacturing there. The same listing names two contract manufacturers: GN ReSound China in Xiamen, and GN ReSound Malaysia in Kulai, Johor. GN Hearing A/S is also their owner-operator, which is why ReSound's name appears in Jabra's FDA records. The listing does not say which site built a given pair.

How the three prices sit against Medicare Advantage caps

A Medicare Advantage cap limits what a plan pays, and it comes with a basis and a period. Jabra Enhance prices are per pair, so the matching caps in the CMS 2026 plan filings are those for both ears combined. We counted contract-plan segments and left out employer-only plans and PACE:

• Every year, 493 segments: lower quartile $1,000, median $2,000, upper quartile $3,000. The median is above all three Jabra Enhance prices and the lower quartile is below all three.
• Every two years, 299 segments: lower quartile $1,500, median $2,200. The median is above all three. The lower quartile is above the M1 price and below the M2 and M3 prices.
• Every three years, 100 segments: lower quartile and median $1,000, upper quartile $2,000. The median is below all three and the upper quartile is above all three.

Per-ear caps run on another basis: 1,056 segments file one every year, with a median of $750 per ear. Of the 5,298 segments with the hearing aid benefit, 3,218 file no plan cap of this kind.

These lines show scale, and three things stop them from showing a payout:

1. Two sections. The caps sit in the filing's main hearing aid section, and over-the-counter aids have their own: 94.6% of 5,599 segments list the first as a built-in benefit and 37.6% list the second.
2. No brand field. We searched every text field in all 7,420 rows of the CMS hearing file for Jabra, GN and ReSound and found no match.
3. Plan rules. Copays, provider networks and approved vendors are set plan by plan.

Before you order, ask your plan whether it pays toward a Jabra purchase, through which provider, and whether a direct purchase counts. This page gives information only and does not recommend or compare Medicare Advantage plans.

Related coverage and cost pages

State-by-state plan caps and copays are on Medicare Advantage hearing aid coverage, and the over-the-counter benefit has its own page: OTC hearing aids and Medicare. For the federal rule, see Medicare hearing aid coverage. To spread or offset the cost, see hearing aid payment plans and FSA eligibility. Return rights by state are on free trial hearing aids.